Sign Up to like & get recommendations! 0
Published in 2021 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2020.9241
Abstract: Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19 Physiologic adaptations and changes in immune regulation may increase the risk of morbidity and mortality in pregnant women with respiratory infections.1,2 The… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.7852
Abstract: Key Points Question Does androgen suppression improve clinical outcomes in hospitalized men with COVID-19? Findings In this randomized clinical trial including 96 men, androgen suppression with the addition of degarelix vs placebo plus standard care… read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28463
Abstract: Therapeutic approaches with immune‐modulatory effects such as probiotics and prebiotics adjuvant therapy may be essential to combat against COVID‐19 pandemic. The present trial aimed to reveal the efficacy of synbiotic supplementation on clinical and paraclinical… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "American journal of infection control"
DOI: 10.1016/j.ajic.2021.09.002
Abstract: BACKGROUND Isolation is effective in preventing transmission of infectious disease. However, it has been shown to have negative effects including increased anxiety and poor physical outcomes. OBJECTIVES To summarize the effects of interventions to improve… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "International Journal of Infectious Diseases"
DOI: 10.1016/j.ijid.2021.03.058
Abstract: Objective To describe the clinical characteristics and outcomes of hospitalized COVID-19 patients in a MERS-CoV referral hospital during the peak months of the pandemic. Design A single-center case series of hospitalized individuals with confirmed SARS-CoV-2… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Influenza and Other Respiratory Viruses"
DOI: 10.1111/irv.12643
Abstract: Respiratory syncytial virus (RSV) is an important cause of morbidity and mortality in adults. Existing studies are limited by the number of seasons studied and most have focused on the immunocompromised. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "BioMed Research International"
DOI: 10.1155/2022/2349890
Abstract: COVID-19 risk increases with comorbidities, and the effect is magnified due to the contribution of individual and combined comorbidities to the overall clinical outcomes. We aimed to explore the influence of demographic factors, clinical manifestations,… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e18626
Abstract: e18626 Background: Pts with malignancies are at risk for developing severe complications of COVID-19 with high mortality rate. We retrospectively analyzed COVID-19 related outcomes for hospitalized pts with SMs. Methods: We collected data on hospitalized… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0264178
Abstract: Renalase is a secreted flavoprotein with anti-inflammatory and pro-cell survival properties. COVID-19 is associated with disordered inflammation and apoptosis. We hypothesized that blood renalase levels would correspond to severe COVID-19 and survival. In this retrospective… read more here.
Sign Up to like & get recommendations! 3
Published in 2023 at "PLOS ONE"
DOI: 10.1371/journal.pone.0286589
Abstract: The Coronavirus Disease 2019 (COVID-19) pandemic posed various challenges to the healthcare system and disease management. This study aimed to describe changes in the clinical characteristics and outcomes of hospitalized patients during the first year… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Medicina"
DOI: 10.3390/medicina58101317
Abstract: Abstract Background: Krebs von den Lungen 6 (KL-6) is a novel biomarker for interstitial lung disease, and it reflects acute lung injury. We explored the usefulness of KL-6 to predict clinical outcomes in hospitalized coronavirus… read more here.